COLUMBUS, Ohio, July 23 (Nationwide Times) — For someone deciding whether tomato juice belongs in a daily routine, the main takeaway is modest: a specially formulated tomato-soy drink lowered several inflammation-related proteins in a small study of adults with obesity, but the finding does not prove that ordinary tomato juice has the same effect.
What the study found
The study, published in Molecular Nutrition & Food Research and indexed in PubMed, tested 12 adults with obesity. Participants drank either a tomato-soy beverage or a low-carotenoid tomato juice control. Each person received two 6-ounce servings a day for four weeks, and the trial used a crossover design with a washout period between the drinks.
After the tomato-soy beverage, the study reported significant decreases in three proteins linked to inflammation: IL-5, IL-12p70 and GM-CSF. TNF-α also moved downward, but the change did not meet conventional statistical significance.
The study also found that plasma lycopene rose 2.48-fold after the tomato-soy drink.
Why those proteins matter
IL-5, IL-12p70, GM-CSF and TNF-α are cytokines, or signaling proteins the immune system uses to communicate. Higher levels of some inflammatory markers are often seen in chronic conditions, including obesity. But a drop in a marker is not the same as proof that a person will have fewer health problems.
This study measured biomarkers, not long-term outcomes such as fewer heart attacks, less diabetes or weight loss. The research does not show that the beverage treats obesity or cures inflammation.
Why this was not just tomato juice
The drink in the study was not ordinary tomato juice. The PubMed abstract says it was made from tomatoes bred to contain high levels of lycopene and was fortified with soy isoflavones.
That matters because the findings do not automatically apply to a standard bottle of tomato juice from the grocery store. The study also found some shared changes in the urine metabolome after both interventions, which suggests that some effects may come from the tomato part of the drink and not only from lycopene.
How strong is the evidence?
The strongest reason for caution is the size of the trial. With only 12 adults, the study is too small to support broad dietary advice on its own. It is best understood as an early signal that a specific combination of tomato compounds and soy compounds may affect inflammation markers.
In other words, the result is promising, but preliminary.
Has tomato juice been studied before?
A separate 2013 randomized study, also indexed in PubMed, found that tomato juice lowered some inflammatory markers in overweight or obese female students at Tehran University of Medical Sciences. In that study, IL-8 and TNF-α fell in the intervention group, and IL-6 decreased in obese participants.
That earlier trial is not the same as the newer tomato-soy study, but it suggests researchers have been looking for links between tomato-based drinks and inflammation for years.
What a normal reader should take from this
The practical message is simple: the new study does not give a reason to treat special tomato drinks as a proven inflammation therapy. It does suggest that ingredients in tomatoes, especially when paired with soy isoflavones, may influence inflammation markers in adults with obesity.
For now, the evidence is still too small for big claims about daily health decisions.
